Oramed Pharmaceuticals
ORMP
#9090
Rank
A$0.18 B
Marketcap
A$4.55
Share price
4.66%
Change (1 day)
15.53%
Change (1 year)

Oramed Pharmaceuticals (ORMP) - Net assets

Net assets on the balance sheet as of June 2025 : A$0.23 Billion

According to Oramed Pharmaceuticals's latest financial reports the company has A$0.23 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Oramed Pharmaceuticals - Net assets on balance sheet (from 2005 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$A$0.23 B-2.26%
2023-12-31$A$0.23 B7.64%
2022-12-31$A$0.22 B
2021-08-31$A$0.15 B257.44%
2020-08-31$A$44.54 M54.77%
2019-08-31$A$28.78 M-33.56%
2018-08-31$A$43.31 M78.77%
2017-08-31$A$24.23 M-30.43%
2016-08-31$A$34.82 M-0.27%
2015-08-31$A$34.92 M56.7%
2014-08-31$A$22.28 M144%
2013-08-31$A$9.13 M148.78%
2012-08-31$A$3.67 M5.38%
2011-08-31$A$3.48 M274.81%
2010-08-31$A$0.92 M-72.05%
2009-08-31$A$3.32 M-38.58%
2008-08-31$A$5.41 M763.68%
2007-08-31$A$0.62 M-211.15%
2006-08-31$-A$0.57 Million839.75%
2005-08-31$-A$0.07 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Ultragenyx Pharmaceutical
RARE
A$24.21 M-89.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
A$40.03 B 17,294.63%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Sanofi
SNY
A$129.31 B 56,089.29%๐Ÿ‡ซ๐Ÿ‡ท France
Compugen
CGEN
A$65.67 M-71.46%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Lexicon Pharmaceuticals
LXRX
A$0.18 B-21.76%๐Ÿ‡บ๐Ÿ‡ธ USA